Status:
NOT_YET_RECRUITING
The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment
Lead Sponsor:
Assiut University
Conditions:
Autoimmune Hemolytic Anemia
Eligibility:
All Genders
Brief Summary
we study the circulating T-follicular regulatory and T-follicular regulatory cells in autoimmune hemolytic anemia.
Detailed Description
Autoimmune hemolytic anemia (AIHA) is an acquired autoimmune disease resulting in the production of antibodies directed against the patient's red blood cells (RBCs) causing shortened erythrocyte lifes...
Eligibility Criteria
Inclusion
- Patients diagnosed as autoimmune hemolytic anemia, primary or secondary, male or female, any age but not on treatment
Exclusion
- Pregnancy or breast-feeding women
- Patients treated with corticoids or immunosuppressant.
- Patients with hematological malignance.
- Patients with alloimmune hemolytic anemia as ABO incompatibility or transplant patients
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04814394
Start Date
April 1 2022
End Date
December 1 2026
Last Update
October 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.